Anticoagulant Therapy after PCI (patients with AFib)
Dual-Therapy Preferred:
• Triple therapy = increased bleeding
- Bleeding risk outweighed ischemic benefit after 1 month
- Unclear if reduced bleeding risk due to use of DOAC (vs VKA) or lack of aspirin
• Periprocedural aspirin given to all patients in clinical trials
- Either continued or stopped at time of randomization)
by Dr. Derick Gabel @derick_gabel via ACCP Cardiology PRN @accpcardprn
#Triple #therapy #anticoagulation #PCI #pharmacology #management #cardiology
